Jianling Li

1.2k total citations
7 papers, 243 citations indexed

About

Jianling Li is a scholar working on Infectious Diseases, Genetics and Hepatology. According to data from OpenAlex, Jianling Li has authored 7 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Genetics and 2 papers in Hepatology. Recurrent topics in Jianling Li's work include Chronic Lymphocytic Leukemia Research (2 papers), Hepatitis C virus research (2 papers) and Advanced Breast Cancer Therapies (1 paper). Jianling Li is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Hepatitis C virus research (2 papers) and Advanced Breast Cancer Therapies (1 paper). Jianling Li collaborates with scholars based in United States, Spain and France. Jianling Li's co-authors include Xiaoping Liu, Shang­rong Fan, Stanislas Pol, Timothy Eley, C Pasquinelli, Patrick Marcellin, Marc Bourlière, Lawrence Serfaty, Shu-Pang Huang and M. Rodríguez‐Torres and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Hepatology.

In The Last Decade

Jianling Li

7 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianling Li United States 5 129 124 94 64 56 7 243
Karin S. Ku United States 8 110 0.9× 117 0.9× 79 0.8× 48 0.8× 37 0.7× 9 232
Roberto Rossotti Italy 9 174 1.3× 151 1.2× 190 2.0× 20 0.3× 27 0.5× 45 377
C. Sarrecchia Italy 9 238 1.8× 231 1.9× 74 0.8× 19 0.3× 11 0.2× 18 331
Carmen Rodríguez-Sáinz Spain 10 70 0.5× 56 0.5× 33 0.4× 48 0.8× 23 0.4× 21 306
C. Rabian France 10 79 0.6× 21 0.2× 70 0.7× 24 0.4× 48 0.9× 15 345
Kalayanee Atamasirikul Thailand 11 194 1.5× 72 0.6× 147 1.6× 15 0.2× 9 0.2× 25 343
Asrul Abdul Wahab Malaysia 11 86 0.7× 62 0.5× 58 0.6× 6 0.1× 13 0.2× 48 274
GianPiero Cadeo Italy 6 167 1.3× 133 1.1× 48 0.5× 37 0.6× 80 1.4× 8 291
Isidro Sanz Pérez Spain 9 90 0.7× 81 0.7× 114 1.2× 36 0.6× 42 0.8× 15 368
Julia O’Brien United Kingdom 9 400 3.1× 399 3.2× 74 0.8× 15 0.2× 26 0.5× 12 510

Countries citing papers authored by Jianling Li

Since Specialization
Citations

This map shows the geographic impact of Jianling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianling Li more than expected).

Fields of papers citing papers by Jianling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianling Li. The network helps show where Jianling Li may publish in the future.

Co-authorship network of co-authors of Jianling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jianling Li. A scholar is included among the top collaborators of Jianling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianling Li. Jianling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Li, Jianling, Rui Luo, & Wei Gao. (2024). Diagnostic value of nasal sinus computed tomography/magnetic resonance imaging examination and serum cytokines in unilateral benign sphenoid sinus lesions. SHILAP Revista de lepidopterología. 18(1). 101187–101187. 2 indexed citations
2.
Palomba, M. Lia, Isabelle Rivière, Devanjan Sikder, et al.. (2023). A Phase I Study of CD19‐targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B‐cell Lymphoma. Hematological Oncology. 41(S2). 527–528. 1 indexed citations
3.
Allan, John N., Tait D. Shanafelt, Adrian Wiestner, et al.. (2021). Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials. British Journal of Haematology. 196(4). 947–953. 38 indexed citations
4.
Buske, Christian, Alessandra Tedeschi, Judith Trotman, et al.. (2018). Ibrutinib Treatment in Waldenström's Macroglobulinemia: Follow-up Efficacy and Safety from the iNNOVATETM Study. Blood. 132(Supplement 1). 149–149. 22 indexed citations
5.
Fan, Shang­rong, et al.. (2014). Vaginal Nystatin Versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal Candidiasis. Mycopathologia. 179(1-2). 95–101. 35 indexed citations
6.
Lok, Anna S., David Gardiner, Christophe Hézode, et al.. (2013). Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders. Journal of Hepatology. 60(3). 490–499. 111 indexed citations
7.
Peng, Joanna, Federico Pulido, Jianling Li, et al.. (2006). Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus–Coinfected Subjects With Hepatic Impairment. The Journal of Clinical Pharmacology. 46(3). 265–274. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026